azacitidine has been researched along with sq-23377 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deguchi, Y; Hara, H; Kishimoto, S; Negoro, S | 1 |
Bagnis, C; Bréchot, C; Chapel, S; Gerolami, R; Jordier, F; Mannoni, P; Uch, R | 1 |
Belkhir, R; Gestermann, N; Koutero, M; Mariette, X; Miceli-Richard, C; Seror, R; Tost, J | 1 |
3 other study(ies) available for azacitidine and sq-23377
Article | Year |
---|---|
5-Azacytidine induced inhibition of mitogenic response by agents that activate or augment activation of human peripheral blood T lymphocytes.
Topics: Adult; Azacitidine; Ethers; Female; Humans; Ionomycin; Lymphocyte Activation; Male; Phytohemagglutinins; Rosette Formation; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thymidine | 1988 |
Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors.
Topics: Azacitidine; Carcinoma, Hepatocellular; Cell Survival; Dexamethasone; Flow Cytometry; Genetic Vectors; Green Fluorescent Proteins; HIV; Humans; Interleukin-6; Ionomycin; Kinetics; Leukemia Virus, Murine; Liver Neoplasms; Luminescent Proteins; Recombinant Proteins; Tetradecanoylphorbol Acetate; Transduction, Genetic; Transgenes; Tumor Cells, Cultured | 2000 |
Upregulation of membrane-bound CD40L on CD4+ T cells in women with primary Sjögren's syndrome.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; CD40 Ligand; Cells, Cultured; DNA Methylation; Female; Gene Expression; Humans; Ionomycin; Lymphocyte Activation; Membrane Proteins; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sjogren's Syndrome; T-Lymphocytes; Tetradecanoylphorbol Acetate; Up-Regulation; Young Adult | 2014 |